Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v17-FR | Version v5-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2022-04-13 | 2021-04-15 |
| Drug Identification Number | 02439379 | 02439379 |
| Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | Ropivacaine Hydrochloride Injection, USP 2 mg/mL freeflex® Bag 200 mL | Ropivacaine Hydrochloride Injection, USP 2 mg/mL freeflex® Bag 200 mL |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 2MG | 2MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | EPIDURAL INFILTRATION INFILTRATION EPIDURAL | EPIDURAL INFILTRATION INFILTRATION EPIDURAL |
| Packaging size | 200 mL | 200 mL |
| ATC code | N01BB | N01BB |
| ATC description | ANESTHETICS, LOCAL | ANESTHETICS, LOCAL |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2021-03-26 | |
| Actual start date | 2021-11-01 | 2021-03-26 |
| Estimated end date | 2022-04-04 | Unknown |
| Actual end date | 2022-04-04 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption on our Ropivacaine Hydrochloride Injection, USP 2 mg/mL freeflex® Bag 200 mL effective November 1, 2021 until January 30, 2022. Our Ropivacaine Hydrochloride Injection, USP 2 mg/mL freeflex® Bag 100 mL will be available for substitution. Allocations will be increased to cover 100% of the 100ml demand plus 50% of the 200ml demand on a 2:1 conversion ratio. For example, 2 vials of 100ml = 1 vial of 200ml. | Product is on 100% Allocation. |
| Health Canada comments |